- February 22, 2026
Loading
TAMPA —Officials from Alzamend Neuro were in Times Square Monday morning July 12 to ring the opening bell at the NASDAQ exchange just days shy of the one-month anniversary of its IPO and as it awaits federal approval to begin early study on a drug to treat Alzheimer's Disease.